Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies
暂无分享,去创建一个
K. Tobinai | K. Ando | Y. Mishima | W. Munakata | K. Ohmachi | N. Fukuhara | Kazuhito Yamamoto | M. Yokoyama | S. Ichikawa | Daisuke Ogiya | S. Fukuhara | Masahiro Hatsumichi | Arata Aoi